<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="16149">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02896647</url>
  </required_header>
  <id_info>
    <org_study_id>ALR_2016_20</org_study_id>
    <nct_id>NCT02896647</nct_id>
  </id_info>
  <brief_title>3D Phase Sensitive Inversion Recuperation MRI to Detect and Characterize Multiple Sclerosis Spinal Cord Lesions</brief_title>
  <acronym>ESPOIR</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <brief_summary>
    <textblock>
      This study aims to assess the interest of 3D Phase Sensitive Inversion Recuperation
      (PSIR)sequence in the MRI detection of spinal cord lesion. It will compare the sensitivity
      of this MRI sequence compared to the T1 and T2 sequences recommended in the assessment of
      neuraxis inflammatory diseases.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>number of spinal cord lesions</measure>
    <time_frame>baseline</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">52</enrollment>
  <condition>Multiple Sclerosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patients scheduled for spinal cord MRI exploration for the assessment of a neuraxis
        inflammatory disease
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age â‰¥ 18 years old

          -  patients scheduled for spinal cord MRI exploration for the assessment of neuraxis
             inflammatory diseases

        Exclusion Criteria:

          -  contraindication to MRI

          -  allergy to contrast media

          -  patient under legal protection

          -  no health insurance coverage

          -  patient's refusal to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Augustin LECLER, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondation OPH A de Rothschild</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laurence SALOMON, MD, PhD</last_name>
    <phone>0033148036431</phone>
    <email>lsalomon@for.paris</email>
  </overall_contact>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>September 7, 2016</lastchanged_date>
  <firstreceived_date>September 7, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Multiple Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
